These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4231826)

  • 1. Recent studies on the mode of action of antidepressive drugs.
    Carlsson A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):115-7. PubMed ID: 4231826
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 3. Alteration in subcellular distribution of amines produced by drugs.
    Lundborg P; Stitzel R
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:47. PubMed ID: 5630942
    [No Abstract]   [Full Text] [Related]  

  • 4. Blockade of noradrenaline uptake by 34276-Ba, a new antidepressant drug.
    Maître L; Staehelin M; Bein HJ
    Biochem Pharmacol; 1971 Sep; 20(9):2169-86. PubMed ID: 5170746
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetic and thermodynamic considerations regarding the inhibition by tricyclic antidepressants of the uptake of tritiated norepinephrine by the adrenergic nerves in rabbit aortic strips.
    Maxwell RA; Eckhardt SB; Hite G
    J Pharmacol Exp Ther; 1970 Jan; 171(1):62-9. PubMed ID: 5410938
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons.
    Lidbrink P; Jonsson G; Fuxe K
    Neuropharmacology; 1971 Sep; 10(5):521-36. PubMed ID: 4399540
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the uptake and subcellular distribution of catecholamines and their alpha-methylated analogues.
    Lundborg P
    Acta Physiol Scand Suppl; 1967; 302():1-34. PubMed ID: 5584149
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 9. The phenyl rings of tricyclic antidepressants and related compounds as determinants of the potency of inhibition of the amine pumps in adrenergic neurons of the rabbit aorta and in rat cortical synaptosomes.
    Maxwell RA; Ferris RM; Burcsu J; Woodward EC; Tang D; Williard K
    J Pharmacol Exp Ther; 1974 Dec; 191(3):418-30. PubMed ID: 4427288
    [No Abstract]   [Full Text] [Related]  

  • 10. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.
    Schildkraut JJ; Schanberg SM; Breese GR; Kopin IJ
    Am J Psychiatry; 1967 Nov; 124(5):600-8. PubMed ID: 4383104
    [No Abstract]   [Full Text] [Related]  

  • 11. Tricyclic antidepressants: evidence for an intraneuronal site of action.
    Reid WD; Stefano FJ; Kurzepa S; Brodie BB
    Science; 1969 Apr; 164(3878):437-9. PubMed ID: 5777215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of imipramine and desipramine on noradrenaline-liberation in sympathetic neurons under calcium-efficiency conditions].
    Ziegler E; Blattner R
    Arzneimittelforschung; 1967 Jun; 17(6):729-31. PubMed ID: 4300744
    [No Abstract]   [Full Text] [Related]  

  • 13. Uptake, storage and release of H3-alpha-methyl norepinephrine.
    Carlsson A; Lundborg P; Stitzel R; Waldeck B
    J Pharmacol Exp Ther; 1967 Nov; 158(2):175-82. PubMed ID: 6065141
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction between imipramine-like agents and catecholamine-induced hyperthemia.
    Jori A; Garattini S
    J Pharm Pharmacol; 1965 Aug; 17(8):480-8. PubMed ID: 4379609
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices.
    Ross SB; Renyi AL; Ogren SO
    Life Sci I; 1971 Nov; 10(22):1267-77. PubMed ID: 5144617
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of drugs upon the uptake of 5-hydroxytryptamine and metaraminol by human platelets.
    Ahtee L; Saarnivaara L
    J Pharm Pharmacol; 1971 Jul; 23(7):495-501. PubMed ID: 4397447
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Pharmacology of the adrenergic mechanism.
    Pfeifer AK
    J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4135935
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-activity relationships for potent phthalane and thiophthalane inhibitors of norepinephrine uptake. A comparison with desipramine and related compounds.
    Maxwell RA; Ferris RM; Woodward EC; Tang FL; Eckhardt SB
    Mol Pharmacol; 1980 May; 17(3):321-7. PubMed ID: 7393212
    [No Abstract]   [Full Text] [Related]  

  • 19. On the mechanism of scorpion toxin-induced release of norepinephrine from peripheral adrenergic neurons.
    Moss J; Thoa NB; Kopin IJ
    J Pharmacol Exp Ther; 1974 Jul; 190(1):39-48. PubMed ID: 4847312
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudo-transmitters.
    Carlsson A
    J Neurovisc Relat; 1969; 31():Suppl 9:249+. PubMed ID: 4319514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.